# Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease

> **NCT07471997** · NA · COMPLETED · sponsor: **Instituto de Oftalmología Fundación Conde de Valenciana** · enrollment: 15 (actual)

## Conditions studied

- Thyroid Eye Disease, TED

## Interventions

- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT07471997
- **Lead sponsor:** Instituto de Oftalmología Fundación Conde de Valenciana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-20
- **Primary completion:** 2025-02-20
- **Final completion:** 2025-02-20
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07471997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07471997, "Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07471997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*